AHR and asthma: As for the animal study (Jin et al., 2019), MSJZT effectively restrained the major characteristic features of asthma such as AHR, inflammatory cytokine, and especially T effector (Teff) cell levels, which occurred, fully or partly, through inhibiting the Mechanistic Target of Rapamycin 1 (mTORC1) signaling pathway in a chronic murine model of asthma.